Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart Disease-Reference-Cited by-同舟云学术

Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart Disease

Published:2010-07 Issue:4 Volume:3 Page:406-412
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Pottala James V.¹,Garg Sachin¹,Cohen Beth E.¹,Whooley Mary A.¹,Harris William S.¹

Affiliation:

1. From the Cardiovascular Health Research Center (J.V.P., W.S.H.), Sanford Research/USD and Sanford School of Medicine, Sioux Falls, SD; Emory University School of Medicine (S.G.), Atlanta, Ga; and Medicine and Epidemiology and Biostatistics (B.E.C., M.A.W.), University of California, San Francisco, and Section of General Internal Medicine, VA Medical Center, San Francisco, Calif.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference51 articles.

1. n−3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review

2. Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

3. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls

4. Dietary Intake and Cell Membrane Levels of Long-Chain n-3 Polyunsaturated Fatty Acids and the Risk of Primary Cardiac Arrest

5. Tissue n−3 and n−6 fatty acids and risk for coronary heart disease events

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: A population-based cohort study in UK Biobank;eLife;2024-04-05

2. Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: a population-based cohort study in UK Biobank;2024-03-01

3. Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial;International Journal of Cardiology;2024-01

4. Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: a population-based cohort study in UK Biobank;ELIFE;2023-11-17

5. Genome-wide association study of Red Blood Cell fatty acids in the Women's Health Initiative Memory Study;Prostaglandins, Leukotrienes and Essential Fatty Acids;2023-07